Sleep disturbance in inflammatory bowel disease: clinical associations and gaps in care
- 31 October 2026
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
Abstract
Background and aims: Sleep disturbance is highly prevalent in inflammatory bowel disease (IBD), affecting up to 70% of patients with active disease and 40% in remission, and is associated with worse clinical and patient-reported outcomes. Understanding of the multifactorial drivers of sleep disturbances in IBD remains limited, and as such, there is an absence of clear guidance for evaluating and managing sleep problems in this population. We aimed to identify factors associated with sleep disturbance and characterize patient beliefs, self-management strategies, and interest in sleep-focused testing and treatments. Methods: Adults with Crohn disease and ulcerative colitis completed a cross-sectional survey assessing disease activity, sleep quality, stress, chronotype, fatigue, and mood. A study-specific questionnaire evaluated sleep-related beliefs, behaviors, and treatment interest. Descriptive analyses characterized sleep patterns and behaviors, and multivariable regression identified factors associated with poor sleep. Results: Among 204 participants, 76.5% reported poor sleep quality and 55.9% had clinically significant sleep disturbance, which was more common in active disease than remission (80.9% vs 46.0%, P < .001). Active disease (odds ratio [OR], 4.31), higher perceived stress (OR, 1.21), and anxiety (OR, 2.63) were associated with increased odds of clinically significant sleep disturbance, while intermediate (OR, 0.16) and morning chronotypes (OR, 0.07) were associated with lower odds of clinically significant sleep disturbance compared with evening chronotypes. Most participants reported self-management behaviors related to sleep, with widespread use of sleep hygiene and over-the-counter strategies but minimal exposure to cognitive behavioral therapy for insomnia (0.5%). Interest in sleep-focused interventions was high, particularly for wearable monitoring, home-based testing, and behavioral and light-based therapies. Conclusion: Sleep disturbance in inflammatory bowel disease is common and reflects interacting inflammatory, psychological, and circadian factors. Use of evidence-based therapies remains extremely limited, highlighting a substantial gap in care.Keywords
This publication has 26 references indexed in Scilit:
- Wearable Devices Identify Altered Sleep Characteristics and Sleep Trajectories in Active Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2025
- Prevalence and risk factors of sleep disorders in inflammatory bowel disease: a cross-sectional studyInternational Journal of Colorectal Disease, 2024
- Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With InsomniaJAMA Network Open, 2023
- Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their GastroenterologistDigestive Diseases and Sciences, 2023
- Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep DisordersDigestive Diseases and Sciences, 2021
- Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors – A cross-sectional studyScientific Reports, 2020
- Sleep Disturbance and Risk of Active Disease in Patients With Crohn's Disease and Ulcerative ColitisClinical Gastroenterology and Hepatology, 2013
- A population-based study of fatigue and sleep difficulties in inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989